N Verses Capital, LLC Pacira Bio Sciences, Inc. Transaction History
N Verses Capital, LLC
- $167 Billion
- Q2 2024
A detailed history of N Verses Capital, LLC transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, N Verses Capital, LLC holds 1,800 shares of PCRX stock, worth $24,930. This represents 0.03% of its overall portfolio holdings.
Number of Shares
1,800
Previous 200
800.0%
Holding current value
$24,930
Previous $5.84 Million
781.21%
% of portfolio
0.03%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding PCRX
# of Institutions
301Shares Held
51.5MCall Options Held
378KPut Options Held
1.53M-
Black Rock Inc. New York, NY8.01MShares$111 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.08MShares$70.4 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA2.16MShares$30 Million0.16% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny2.07MShares$28.6 Million0.1% of portfolio
-
State Street Corp Boston, MA1.9MShares$26.4 Million0.0% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $635M
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...